Information  X 
Enter a valid email address

Antisoma plc (SRC)

  Print      Mail a friend       Annual reports

Monday 23 May, 2005

Antisoma plc

Antisoma to present at Needham & Company Fo...

23 May 2005, London, UK - Antisoma plc (LSE: ASM) today announces
that its Chief Executive Officer, Glyn Edwards, will be presenting at
the Needham & Company Fourth Annual Biotechnology Conference in New
York, USA.

Mr Edwards's presentation is scheduled for 14.30 EST on Thursday, May
26, with an additional breakout session at 15.00. A webcast of the
presentation will be available to all on Antisoma's website at

It is recommended that viewers log on 15 minutes early in order to
register and download any necessary software. If you are unable to
participate during the live web cast, a recorded replay of the
presentation will be available for 90 days.


Margherita Lupi
+44 (0)20 8799 8200
Corporate Communications Manager
Antisoma plc

Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products
for the treatment of cancer. Antisoma fills its development pipeline
by acquiring promising new product candidates from internationally
recognised academic or cancer research institutions. Its core
activity is the preclinical and clinical development of these drug
candidates. In November 2002, Antisoma formed a broad strategic
alliance with Roche to develop and commercialise products from
Antisoma's pipeline. Please visit for further